Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy, immunogenicity, and safety of different dose schedules for GSK's malaria vaccine in malaria-naïve adults; completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Malaria vaccine (GSK candidate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Malaria | Phase 2 | Status: COMPLETED | Results posted: 2019-07-24